Full-Time

Sr. Director

Biopharma Supplier Strategy & Market Intelligence

Confirmed live in the last 24 hours

McKesson

McKesson

Healthcare distribution and logistics services

Enterprise Software
Healthcare

Compensation Overview

$132.2k - $220.3kAnnually

+ Annual Bonus + Long-term Incentive Opportunities

Senior, Expert

Montreal, QC, Canada + 1 more

More locations: Mississauga, ON, Canada

The job is based in Canada, specifically in Quebec and Ontario.

Category
Project Management
Strategy Development
Business & Strategy
Required Skills
Data Analysis

You match the following McKesson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Business, Healthcare Administration, Life Sciences, or a related field (MBA or advanced degree an asset).
  • Minimum of 10 years of relevant experience in strategy development, market intelligence, or a related field within the biopharma industry.
  • Minimum of 4+ years of leadership experience in strategy development, market intelligence, biopharma or related field.
  • Proven leadership experience with a track record of driving strategic initiatives and managing cross-functional collaboration in a matrix organization.
Responsibilities
  • Lead the development and implementation of manufacturer strategies for McKesson Canada across various therapeutic areas and product categories, with a primary focus on Brand pharmaceutical manufacturers.
  • Develop and maintain a robust pipeline outlook to anticipate and capitalize on upcoming product launches and market shifts.
  • Understand market dynamics and trends within therapeutic areas and how they impact product categories.
  • Understand manufacturer unmet needs at a customer segment and individual manufacturer level.
  • Assess current relationships and business portfolios and marry with market insights to translate into specific strategies for each manufacturer reflecting the opportunities to grow mutually beneficial relationships.
  • Collaborate with internal stakeholders to socialize, refine manufacturer strategies and ensure alignment and execution of strategies that enhance McKesson Canada's competitive position. Where necessary, facilitate process to make informed trade-offs across teams and/or manufacturers.
  • Support PSSP teams, primarily the Account Management team, in development of their account planning and strategy development through analysis to inform risks and opportunities. Participate in partner meetings and business reviews as requested.
  • Articulate McKesson Canada's value proposition to manufacturers in way that resonates with manufacturers and effectively communicates McKesson Canada's unique strengths and capabilities.
  • Develop and execute strategy to expand and enhance McKesson’s value proposition to continue to bring value and address unmet needs of manufacturers.
  • Drive manufacturer focused initiatives by coordinating cross-functional efforts and managing projects from inception to completion. - Ensure initiatives are executed effectively and deliver the intended outcomes.
  • Shape and nurture a positive organizational culture where every team member feels valued and empowered to contribute to the collective success of the team, and that aligns with McKesson Canada core values and strategic goals.
Desired Qualifications
  • Strong knowledge of the biopharma (including manufacturer and distribution) space and deep understanding of pharma customer needs.
  • Expertise in market analysis and the ability to translate insights into actionable strategies. Proven track record in strategy development and market intelligence in the biopharma sector.
  • Ability to influence and drive alignment and coordination across diverse stakeholders.
  • Business partner mindset with a strong service orientation.
  • Outstanding communication skills, both written and verbal.
  • Experience leading strategic planning processes for a biopharma company or distribution organization with manufacturer exposure an asset.
  • Experience working across multiple therapeutic areas within the biopharma industry an asset.

McKesson Corporation operates in the healthcare sector, focusing on the distribution of medical products and pharmaceuticals. The company acts as a middleman, purchasing medical supplies from manufacturers and delivering them to healthcare providers, pharmacies, and hospitals. This ensures that essential medical products are available when needed, supporting the healthcare system. McKesson generates revenue by marking up the cost of the products they distribute and charging service fees for logistics and supply chain management. They also provide technology solutions to help healthcare providers improve their operations. McKesson's goal is to enhance patient care by ensuring timely access to medical supplies and services through a well-established network and partnerships.

Company Size

N/A

Company Stage

IPO

Total Funding

$7.6M

Headquarters

Irving, Texas

Founded

1833

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of PRISM Vision boosts earnings and expands provider network.
  • Increased demand for digital health solutions enhances McKesson's technology offerings.
  • Growing chronic disease prevalence boosts demand for McKesson's home healthcare services.

What critics are saying

  • Rogers distribution center closure may disrupt local supply chain operations.
  • PRISM Vision acquisition poses integration challenges and financial risks.
  • InspiroGene launch may face regulatory hurdles and market competition.

What makes McKesson unique

  • McKesson's extensive network ensures timely delivery of medical supplies globally.
  • The company offers technology solutions to enhance healthcare providers' operational efficiency.
  • McKesson's strategic partnerships strengthen its role in the global healthcare supply chain.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

Company News

Stock Titan
Feb 4th, 2025
Major Healthcare Acquisition: McKesson Takes Control of PRISM Vision in Strategic $850M Move

McKesson acquires 80% stake in PRISM Vision for $850M, adding 180+ providers across 91 locations. Deal expected to boost earnings by up to $0.75 per share within 3 years.

Slater Sentinel
Jan 17th, 2025
Empirical Asset Management LLC Makes New Investment in McKesson Co. (NYSE:MCK)

Empirical Asset Management LLC makes new investment in McKesson Co. (NYSE:MCK).

UIC Today
Jan 17th, 2025
UIC Retzky College of Pharmacy receives grant to address rural pharmacist shortage

The University of Illinois Chicago's Retzky College of Pharmacy received a grant totaling $864,000 from the McKesson Foundation to support rural-focused interventions to develop and train pharmacy professionals to serve rural populations.

Slater Sentinel
Jan 13th, 2025
Parisi Gray Wealth Management Makes New $225,000 Investment in McKesson Co. (NYSE:MCK)

Parisi Gray Wealth Management makes new $225,000 investment in McKesson Co. (NYSE:MCK).

Drug Discovery Trends
Jan 10th, 2025
Merck taps Atropos Health to accelerate real-world evidence generation

In May 2024, Atropos Health raised $33 million in funding, with participation from Cencora Ventures, McKesson Ventures, and Merck Global Health Innovation Fund.

MarketBeat
Dec 15th, 2024
World Investment Advisors LLC Invests $2.23 Million in McKesson Co. (NYSE:MCK)

World Investment Advisors LLC invests $2.23 million in McKesson Co. (NYSE:MCK).

MWBN
Dec 13th, 2024
McKesson closing Rogers distribution center, laying off 83

McKesson Corp. will close a distribution center in Rogers, laying off 83 employees there, starting in March, according to a WARN letter the company filed with the state.

MarketBeat
Nov 29th, 2024
Peterson Wealth Management Invests $938,000 in McKesson Co. (NYSE:MCK)

Peterson Wealth Management invests $938,000 in McKesson Co. (NYSE:MCK).

MarketBeat
Nov 12th, 2024
Chartwell Investment Partners LLC Makes New Investment in McKesson Co. (NYSE:MCK)

Chartwell Investment Partners LLC makes new Investment in McKesson Co. (NYSE:MCK).

Bakersfield.com
Oct 1st, 2024
McKesson Launches InspiroGene, a Dedicated Business to Guide and Support the Commercialization of Cell and Gene Therapies

McKesson Corporation today announced the launch of InspiroGene(TM) by McKesson ("InspiroGene"), a dedicated business focused solely on supporting the commercialization of cell and gene therapies (CGTs).

Yahoo Finance
Sep 6th, 2024
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill

McKesson Corporation MCK has agreed to sell its Rexall and Well.ca businesses, both based in Canada, to Birch Hill Equity Partners, a Canadian private equity firm.